Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CYMBALTA | Eli Lilly | N-021427 RX | 2004-08-03 | 3 products, RLD, RS |
DRIZALMA SPRINKLE | Sun Pharmaceutical Industries | N-212516 RX | 2019-07-19 | 4 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
cymbalta | New Drug Application | 2024-11-06 |
drizalma sprinkle | New Drug Application | 2024-05-14 |
duloxetine | ANDA | 2025-07-25 |
duloxetine d/r | ANDA | 2025-07-25 |
duloxetine delayed-release | ANDA | 2017-04-21 |
duloxetine duloxetine | ANDA | 2025-04-03 |
duloxetine duloxetine hydrochloride | ANDA | 2017-08-14 |
duloxetine hcl | ANDA | 2024-12-31 |
duloxetine hydrochloride | ANDA | 2025-06-08 |
duloxicaine | unapproved drug other | 2023-01-25 |
Expiration | Code | ||
---|---|---|---|
DULOXETINE HYDROCHLORIDE, CYMBALTA, LILLY | |||
2023-04-20 | NPP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Intellectual disability | D008607 | EFO_0003847 | F73 | — | — | — | 1 | — | 1 |
Tardive dyskinesia | D000071057 | — | G24.01 | — | — | — | 1 | — | 1 |
Dyskinesias | D020820 | — | G24 | — | — | — | 1 | — | 1 |
Developmental disabilities | D002658 | EFO_0003852 | F89 | — | — | — | 1 | — | 1 |
Drug common name | Duloxetine |
INN | duloxetine |
Description | (S)-duloxetine is a duloxetine. It is an enantiomer of a (R)-duloxetine. |
Classification | Small molecule |
Drug class | antidepressants (fluoxetine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CNCC[C@H](Oc1cccc2ccccc12)c1cccs1 |
PDB | — |
CAS-ID | 116539-59-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1175 |
ChEBI ID | 36795 |
PubChem CID | 60835 |
DrugBank | DB00476 |
UNII ID | O5TNM5N07U (ChemIDplus, GSRS) |